MX2018001528A - Composicion farmaceutica que comprende sumatriptan para tratamiento de migraña. - Google Patents
Composicion farmaceutica que comprende sumatriptan para tratamiento de migraña.Info
- Publication number
- MX2018001528A MX2018001528A MX2018001528A MX2018001528A MX2018001528A MX 2018001528 A MX2018001528 A MX 2018001528A MX 2018001528 A MX2018001528 A MX 2018001528A MX 2018001528 A MX2018001528 A MX 2018001528A MX 2018001528 A MX2018001528 A MX 2018001528A
- Authority
- MX
- Mexico
- Prior art keywords
- sumatriptan
- pharmaceutical composition
- migraine treatment
- migraine
- composition
- Prior art date
Links
- KQKPFRSPSRPDEB-UHFFFAOYSA-N sumatriptan Chemical compound CNS(=O)(=O)CC1=CC=C2NC=C(CCN(C)C)C2=C1 KQKPFRSPSRPDEB-UHFFFAOYSA-N 0.000 title abstract 2
- 229960003708 sumatriptan Drugs 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- KQKPFRSPSRPDEB-XERRXZQWSA-N 1-[3-[2-[bis(trideuteriomethyl)amino]ethyl]-1h-indol-5-yl]-n-methylmethanesulfonamide Chemical compound C1=C(CS(=O)(=O)NC)C=C2C(CCN(C([2H])([2H])[2H])C([2H])([2H])[2H])=CNC2=C1 KQKPFRSPSRPDEB-XERRXZQWSA-N 0.000 abstract 1
- 208000006561 Cluster Headache Diseases 0.000 abstract 1
- 208000019695 Migraine disease Diseases 0.000 abstract 1
- 208000018912 cluster headache syndrome Diseases 0.000 abstract 1
- 206010027599 migraine Diseases 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
La presente solicitud se relaciona a un método de tratamiento de migraña o terrible dolor de cabeza en un paciente humano, el método que comprende administrar la vcomposición subcutáneamente que comprende sumatriptán o su sal farmacéuticamente aceptable, en una cantidad equivalente a 3 mg de base de sumatriptán.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN4076CH2015 | 2015-08-05 | ||
| US15/011,357 US10537554B2 (en) | 2015-08-05 | 2016-01-29 | Pharmaceutical composition for treating migraine |
| PCT/US2016/015961 WO2017023361A1 (en) | 2015-08-05 | 2016-02-01 | Pharmaceutical composition comprising sumatripan for treating migraine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2018001528A true MX2018001528A (es) | 2018-04-24 |
| MX385725B MX385725B (es) | 2025-03-18 |
Family
ID=58053922
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2018001528A MX385725B (es) | 2015-08-05 | 2016-02-01 | Composición farmacéutica que comprende sumatriptán para tratamiento de migraña. |
Country Status (6)
| Country | Link |
|---|---|
| US (4) | US10537554B2 (es) |
| EP (1) | EP3331524A1 (es) |
| CN (1) | CN107921023A (es) |
| BR (1) | BR112018002433A2 (es) |
| CA (1) | CA2994748C (es) |
| MX (1) | MX385725B (es) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10537554B2 (en) | 2015-08-05 | 2020-01-21 | Upsher-Smith Laboratories, Llc | Pharmaceutical composition for treating migraine |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1170387B (it) * | 1982-06-07 | 1987-06-03 | Glaxo Group Ltd | Composti eterociclici, procedimento per prepararli e composizioni farmaceutiche che li contengono |
| US10537554B2 (en) | 2015-08-05 | 2020-01-21 | Upsher-Smith Laboratories, Llc | Pharmaceutical composition for treating migraine |
-
2016
- 2016-01-29 US US15/011,357 patent/US10537554B2/en active Active
- 2016-02-01 EP EP16706279.3A patent/EP3331524A1/en not_active Withdrawn
- 2016-02-01 CA CA2994748A patent/CA2994748C/en active Active
- 2016-02-01 BR BR112018002433-3A patent/BR112018002433A2/pt not_active Application Discontinuation
- 2016-02-01 MX MX2018001528A patent/MX385725B/es unknown
- 2016-02-01 CN CN201680050798.8A patent/CN107921023A/zh active Pending
-
2019
- 2019-12-18 US US16/718,414 patent/US11364224B2/en active Active
-
2022
- 2022-06-06 US US17/833,105 patent/US12097183B2/en active Active
-
2024
- 2024-07-25 US US18/783,734 patent/US20250017902A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US20250017902A1 (en) | 2025-01-16 |
| CA2994748C (en) | 2024-02-13 |
| US20220387386A1 (en) | 2022-12-08 |
| CA2994748A1 (en) | 2017-02-09 |
| MX385725B (es) | 2025-03-18 |
| US20200171000A1 (en) | 2020-06-04 |
| BR112018002433A2 (pt) | 2018-09-18 |
| US20170035729A1 (en) | 2017-02-09 |
| EP3331524A1 (en) | 2018-06-13 |
| US11364224B2 (en) | 2022-06-21 |
| CN107921023A (zh) | 2018-04-17 |
| US10537554B2 (en) | 2020-01-21 |
| US12097183B2 (en) | 2024-09-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2024010140A (es) | Nuevos metodos. | |
| MX393855B (es) | Terapia de combinación que comprende un inhibidor de raf y trametinib | |
| MX2017015938A (es) | Inhibidores de ezh2 para el tratar linfomas. | |
| MX2021000071A (es) | Uso de pridopidina para mejorar la funcion cognitiva y para tratamiento de enfermedad de alzheimer. | |
| MX2021004639A (es) | Combinaciones de inhibidores de desmetilasa-1 especifica de lisina (lsd1) para uso en el tratamiento de tumores solidos. | |
| MX384403B (es) | Terapia de combinación para el tratamiento del cáncer. | |
| MY186977A (en) | Tetrasubstituted alkene compounds and their use | |
| BR112017017448A2 (pt) | métodos e composições para o tratamento de doença do olho ressecado e outros distúrbios do olho | |
| PE20190338A1 (es) | Metodos de tratamiento de trastornos del desarrollo con gaboxadol | |
| MX382162B (es) | Combinaciones farmacéuticas de un inhibidor de enzima hdac con un inhibidor de proteasoma, y su uso en el tratamiento de cáncer. | |
| TW201613578A (en) | Pharmaceutical combinations | |
| PH12016502352A1 (en) | Pharmaceutical composition | |
| MA39765A (fr) | Formulation pharmaceutique d'un inhibiteur de la kinase pan-raf, ses procédés de préparation, et procédés d'utilisation | |
| PH12020550462A1 (en) | Cocrystals, pharmaceutical compositions thereof, and methods of treatment involving same | |
| MX389336B (es) | Formulacion farmaceutica. | |
| EA201692111A1 (ru) | Фармацевтические композиции, содержащие данириксин, для лечения инфекционных заболеваний | |
| PH12016502233A1 (en) | (s)-pirlindole or its pharmaceutically acceptable salts for use in medicine | |
| AR091724A1 (es) | Tratamiento de la esclerosis multiple con una combinacion de laquinimod y fampridina, composicion farmaceutica | |
| MX2018014129A (es) | Composiciones farmaceuticas de oligomero de morfolino fosforodiamidato. | |
| BR112018014723A2 (pt) | fantasmas bacterianos para o tratamento de câncer | |
| EA202193276A1 (ru) | Способы лечения холангиокарциномы | |
| PH12016502236A1 (en) | (r)-pirlindole and its pharmaceutically acceptable salts for use in medicine | |
| SG10201809673RA (en) | Treatment of androgen deprivation therapy associated symptoms | |
| MX2018001528A (es) | Composicion farmaceutica que comprende sumatriptan para tratamiento de migraña. | |
| AR103636A1 (es) | Métodos de tratamiento de neuralgia postherpética con una formulación tópica de un compuesto de espiro-oxindol |